← back to search

Xue‐Qun Luo

Sun Yat-sen University · CN
Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Retinoids in leukemia and cellular processes, and Cancer-related molecular mechanisms research.
h-index
25
citations
2,397
works
111
NIH funding
primary concept
email

Recent publications

Epidemiology, clinical features, and molecular basis of <i>TTMV</i> :: <i>RARA</i> -driven acute promyelocytic leukemia
Blood 2025cited by 3position: middledoi
Cystine-Modified Lignin–Copper Coordination Nanocarriers Improve the Therapeutic Efficacy of Tyrosine Kinase Inhibition via Cuproptosis
ACS Applied Materials & Interfaces 2025cited by 3position: middledoi
The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening
Frontiers in Oncology 2023cited by 17position: middledoi
A multicenter phase <scp>II</scp> trial of primary prophylactic <scp>PEG‐rhG‐CSF</scp> in pediatric patients with solid tumors and <scp>non‐Hodgkin</scp> lymphoma after chemotherapy: An interim analysis
Cancer Medicine 2023cited by 4position: middledoi
Chromatin-associated orphan snoRNA regulates DNA damage-mediated differentiation via a non-canonical complex
Cell Reports 2022cited by 48position: middledoi
Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis
Nature Communications 2022cited by 41position: middledoi
Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels
Molecular Therapy — Oncolytics 2022cited by 36position: middledoi
The snoRNA-like lncRNA LNC-SNO49AB drives leukemia by activating the RNA-editing enzyme ADAR1
Cell Discovery 2022cited by 34position: middledoi
A Nomogram for Predicting Event-Free Survival in Childhood Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study
Frontiers in Oncology 2022cited by 5position: middledoi
The oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation
Molecular Cell 2021cited by 116position: middledoi
Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus
Archivum Immunologiae et Therapiae Experimentalis 2021cited by 44position: lastdoi
Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children’s Leukemia Group
Frontiers in Oncology 2021cited by 24position: middledoi
Performance of PRISM III, PELOD-2, and P-MODS Scores in Two Pediatric Intensive Care Units in China
Frontiers in Pediatrics 2021cited by 22position: lastdoi
Abnormal thymic B cell activation and impaired T cell differentiation in pristane-induced lupus mice
Immunology Letters 2021cited by 9position: lastdoi
The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia
Journal of Hematology & Oncology 2020cited by 90position: middledoi
Arsenic trioxide and all-trans retinoic acid suppress the expression of FLT3-ITD
Leukemia & lymphoma/Leukemia and lymphoma 2020cited by 18position: lastdoi
circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression
Blood 2019cited by 280position: middledoi
circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression
Journal of Hematology & Oncology 2019cited by 76position: middledoi
LncRNA ANRIL regulates AML development through modulating the glucose metabolism pathway of AdipoR1/AMPK/SIRT1
Molecular Cancer 2018cited by 157position: middledoi
MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47
Molecular Cancer 2018cited by 61position: middledoi
The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway
Cell Death and Differentiation 2016cited by 249position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ke Fang · Shandong Normal University9 papers (2016–2022)Wentao Wang · Public Agenda9 papers (2016–2022)Wei Huang · Southeast University9 papers (2016–2022)Yujie Chen · Army Medical University8 papers (2016–2022)Yumeng Sun · Rochester Institute of Technology8 papers (2016–2022)Yan‐Lai Tang · Sun Yat-sen University7 papers (2020–2025)Lin-Ying Sun · Sun Yat-sen University7 papers (2018–2022)Cai Han · Fujian Medical University7 papers (2018–2022)Zhan‐Cheng Zeng · Sun Yat-sen University6 papers (2019–2022)Qi Pan · IHI Corporation (United States)6 papers (2019–2022)Tian-Qi Chen · Sun Yat-sen University5 papers (2019–2022)Zhenhua Chen · Ningbo University4 papers (2016–2019)Chun-Jin Peng · Shenzhen Maternity and Child Healthcare Hospital3 papers (2020–2021)Libin Huang · Sun Yat-sen University3 papers (2020–2025)Qianqian Yang · First Affiliated Hospital of Hebei Medical University3 papers (2019–2021)Wenyan Tang · Hunan Agricultural University2 papers (2020–2021) · 2 papers (2022–2022)Qiting Wu · Anhui Medical University2 papers (2022–2022)Dan-Ping Huang · Guangdong Pharmaceutical University2 papers (2020–2021)Zhaoyang Tang · Nanjing Agricultural University2 papers (2022–2022)